COVID-19 Outcomes Among People With HIV and COVID-19 in New York City
The Journal of Infectious Diseases · 2023
DOI: 10.1093/infdis/jiad311 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2023. Verfasst von Sarah L Braunstein und 2 weiteren Autor:innen. Beteiligte Einrichtung: Bureau of Hepatitis, HIV, and Sexually Transmitted Infections, New York City Department of Health and Mental Hygiene, Long Island City, New York, USA. Hauptthemen laut MEDLINE: COVID-19, HIV Infections. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: CDC HHS, Centers for Disease Control and Prevention.
Abstract (Originalsprache)
Background
Literature on the impact of human immunodeficiency virus (HIV) on coronavirus disease 2019 (COVID-19)–related outcomes remains mixed. Few studies have evaluated COVID-19 outcomes by HIV status using population-based data.
Methods
Using data from New York City COVID-19 surveillance and HIV surveillance systems prior to the widespread availability of COVID-19 vaccines, we conducted a retrospective cohort study comparing the risk of COVID-19 hospitalization and mortality by HIV status among severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnoses from 29 February to 17 October 2020.
Results
Risk of hospitalization and death among people with HIV (PWH) withCOVID-19 were both nearly 30% higher compared with people without HIV. In crude models, incidence of adverse COVID-19 outcomes among PWH compared to people without HIV was elevated in certain groups, including women, and black, Hispanic/Latino, Native American, and multiracial people. CD4 cell count at SARS-CoV-2 diagnosis and presence of an underlying, non-HIV–related condition were independently and strongly associated with risk for COVID-19 hospitalization and death among PWH.
Conclusions
New Yorkers with HIV experienced elevated risk for poor COVID-19 outcomes compared to those without HIV during 2020. PWH, particularly those with low CD4 counts or underlying conditions, should be an ongoing focus for COVID-19 vaccination and rigorous identification and treatment of SARS-CoV-2 infections to prevent adverse outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bureau of Hepatitis, HIV, and Sexually Transmitted Infections, New York City Department of Health and Mental Hygiene, Long Island City, New York, USA.
ORCID-Profile: Sarah L Braunstein
Förderung
- CDC HHS
- Centers for Disease Control and Prevention
Zitieren
APA
Braunstein, S. L., Wahnich, A., & Lazar, R. (2023). COVID-19 Outcomes Among People With HIV and COVID-19 in New York City. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad311
Vancouver
Braunstein SL, Wahnich A, Lazar R. COVID-19 Outcomes Among People With HIV and COVID-19 in New York City. The Journal of Infectious Diseases. 2023. doi:10.1093/infdis/jiad311
BibTeX
@article{Braunstein2023,
author = {Braunstein, Sarah L and Wahnich, Amanda and Lazar, Rachael},
title = {COVID-19 Outcomes Among People With HIV and COVID-19 in New York City},
journal = {The Journal of Infectious Diseases},
year = {2023},
doi = {10.1093/infdis/jiad311}
}
EUVIMED